Attached files
file | filename |
---|---|
10-Q - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v193834_10q.htm |
EX-31.1 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v193834_ex31-1.htm |
EX-32.2 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v193834_ex32-2.htm |
EX-31.2 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v193834_ex31-2.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report
of Weikang Bio-Technology Group Company, Inc. (the "Company") on Form 10-Q for
the period ending June 30, 2010 as filed with the Securities and Exchange
Commission on the date hereof (the "Report"), I, Yin Wang, certify, pursuant to
18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of
2002, that to my knowledge:
|
(1)
|
The
Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934;
and
|
|
(2)
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
Date:
August 13, 2010
/s/ Yin Wang
|
|
Yin
Wang, Chief Executive Officer
|
|
(Principal
Executive Officer)
|